Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity

被引：0

作者：

Noortje M van Maarseveen

Dan Andersson

Martin Lepšík

Axel Fun

Pauline J Schipper

Dorien de Jong

Charles AB Boucher

Monique Nijhuis

机构：

[1] University Medical Center Utrecht,Dept. of Medical Microbiology, Virology

[2] Institute of Organic Chemistry and Biochemistry,Gilead Sciences and IOCB Research Center Prague

[3] v.v.i.,Dept. of Virology

[4] Academy of Science of the Czech Republic,undefined

[5] Erasmus Medical Center,undefined

来源：

Retrovirology | / 9卷

关键词：

HIV-1; Protease; Resistance; Gag; Cleavage; Replicative capacity; NC/p1;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis
Prince, Jessica L.
Claiborne, Daniel T.
Carlson, Jonathan M.
Schaefer, Malinda
Yu, Tianwei
Lahki, Shabir
Prentice, Heather A.
Yue, Ling
Vishwanathan, Sundaram A.
Kilembe, William
Goepfert, Paul
Price, Matthew A.
Gilmour, Jill
Mulenga, Joseph
Farmer, Paul
Derdeyn, Cynthia A.
Tang, Jiaming
Heckerman, David
Kaslow, Richard A.
Allen, Susan A.
Hunter, Eric
[J]. PLOS PATHOGENS, 2012, 8 (11)
[32] Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy
Giandhari, Jennifer
Basson, Adriaan E.
Sutherland, Katherine
Parry, Chris M.
Cane, Patricia A.
Coovadia, Ashraf
Kuhn, Louise
Hunt, Gillian
Morris, Lynn
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2248 - 2256
[33] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
Marcelin, A. G.
Lambert-Niclot, S.
Canestri, A.
Soulie, C.
Wirden, M.
Tubiana, R.
Cheret, A.
Katlama, C.
Flandre, P.
Calvez, V.
[J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A51 - A51
[34] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
Lambert-Niclot, Sidonie
Flandre, Philippe
Malet, Isabelle
Canestri, Ana
Soulie, Cathia
Tubiana, Roland
Brunet, Christel
Wirden, Marc
Katlama, Christine
Calvez, Vincent
Marcelin, Anne-Genevieve
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 905 - 908
[35] A Cleavage Enzyme-Cytometric Bead Array Provides Biochemical Profiling of Resistance Mutations in HIV-1 Gag and Protease
Breuer, Sebastian
Sepulveda, Homero
Chen, Yu
Trotter, Joseph
Torbett, Bruce E.
[J]. BIOCHEMISTRY, 2011, 50 (20) : 4371 - 4381
[36] HIV p7/p1 and p1/p6-gag cleavage site mutations are associated with specific PR mutations and PI resistance profiles.
Verheyen, J.
Litau, E.
Sing, T.
Schuldenzucker, U.
Däumer, M.
Oette, M.
Lengauer, T.
Hoffmann, D.
Pfister, H.
Kaiser, R.
[J]. ANTIVIRAL THERAPY, 2006, 11 (05) : S65 - S65
[37] Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients
Malet, Isabelle
Roquebert, Benedicte
Dalban, Cecile
Wirden, Marc
Amellal, Bahia
Agher, Rachid
Simon, Anne
Katlama, Christine
Costagliola, Dominique
Calvez, Vincent
Marcelin, Anne-Genevieve
[J]. JOURNAL OF INFECTION, 2007, 54 (04) : 367 - 374
[38] HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
Duffy, JL
Kirk, BA
Kevin, NJ
Chapman, KT
Schleif, WA
Olsen, DB
Stahlhut, M
Rutkowski, CA
Kuo, LC
Jin, LX
Lin, JH
Emini, EA
Tata, JR
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3323 - 3326
[39] HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation
Hsieh, Shih-Han
Yu, Fu-Hsien
Huang, Kuo-Jung
Wang, Chin-Tien
[J]. JOURNAL OF VIROLOGY, 2023, 97 (09)
[40] HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation
Hsieh, Shih-Han
Yu, Fu-Hsien
Huang, Kuo-Jung
Wang, Chin-Tien
[J]. JOURNAL OF VIROLOGY, 2023,

← 1 2 3 4 5 →